Evidence map›Paper›PMID 40198496›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Unprecedented "off-pathway" [2+2] Cycloaddition-Retroelectrocyclization Reaction Between an Unsymmetric Alkyne and Tetracyanoquinodimethane.

Oscar Fernández-Vera, Luca Sagresti, Luis M Mateo, Tomas Torres, Giuseppe Brancato, Giovanni Bottari

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oscar Fernández-VeraDepartamento de Química Orgánica, Universidad Autónoma de Madrid, Campus de Cantoblanco, Madrid, 28049, Spain.
Luca SagrestiScuola Normale Superiore and CSGI, Piazza dei Cavalieri 7, Pisa, I-56126, Italy.
Luis M MateoDepartamento de Química Orgánica, Universidad Autónoma de Madrid, Campus de Cantoblanco, Madrid, 28049, Spain.
Tomas TorresDepartamento de Química Orgánica, Universidad Autónoma de Madrid, Campus de Cantoblanco, Madrid, 28049, Spain.
Giuseppe BrancatoScuola Normale Superiore and CSGI, Piazza dei Cavalieri 7, Pisa, I-56126, Italy.
Giovanni BottariDepartamento de Química Orgánica, Universidad Autónoma de Madrid, Campus de Cantoblanco, Madrid, 28049, Spain.

Funding

Comunidad de Madrid and the Spanish State through the Recovery, Transformation, and Resilience PlanEuropean UnionEuropean Union NextGenerationEU/PRTR PID2020-116490GB-I00European Union NextGenerationEU/PRTR TED2021-131255B-C43MECD"Severo Ochoa" Programme for Centers of Excellence in R&D CEX2020-001039-SSpanish MCIN/AEI/10.13039/501100011033
6 · The paper itself

Abstract

In recent years, the [2+2] cycloaddition-retroelectrocyclization (CA-RE) reaction between electron-rich alkynes and electron-deficient alkenes has emerged as one of the most effective synthetic routes to prepare a large variety of molecular and polymeric electron donor-acceptor systems. Besides its simplicity, fast rate, and high yield, this reaction may also display complete and predictable regioselectivity, as in the case when tetracyanoquinodimethane (TCNQ) is used in combination with unsymmetric, activated alkynes. Here, we report the first example of a [2+2] CA-RE reaction between TCNQ and an aniline-activated alkyne following an "inverted" regiochemistry, thus leading to the exclusive formation of an unexpected regioisomer in contrast to the expected one. A combined experimental and theoretical study helped us to unravel the peculiar reaction mechanism underlying the regioselectivity switching.

Indexed as

Anthryl‐fused derivativeCyano‐Diels–Alder reactionCycloaddition‐retroelectrocyclization reactionRegioselectivityTetracyanoquinodimethane

Identifiers

PMID40198496
PMCPMC12144899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.